NCT06789094 · NOT YET RECRUITING

Validating the Ain Shams Cognitive Assessment Tool

This study is testing a new cognitive screening tool called the Ain Shams University Cognitive Assessment, or ASCA, to see how accurately it identifies mild cognitive impairment and dementia. Researchers will compare its performance against established clinical diagnostic standards. This is a validation study, not a drug or treatment trial — it is about improving how cognitive decline gets detected, particularly in Arabic-speaking older adults.

Eligibility criteria

Inclusion Criteria: older adult participants 60 years old and above who are native Arabic speakers
-
Exclusion Criteria:
* severe dementia, delirium, major mental disorders, aphasia, and those with severe visual or hearing impairment that interfere with the assessment.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-01-23

View full record on ClinicalTrials.gov

All APOE4 clinical trials